ImClone and Squibb plan new tests of cancer drug
ImClone Systems Inc. and Bristol-Myers Squibb Co.,under criticism from cancer patients for not moving swiftly enough have said that they will soon begin several clinical trials aimed at winning
ImClone Systems Inc. and Bristol-Myers Squibb Co.,under criticism from cancer patients for not moving swiftly enough have said that they will soon begin several clinical trials aimed at winning